Navigation Links
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
Date:11/3/2010

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- Coronado Biosciences, Inc., a privately held company engaged in innovative oncology drug development, announced completion of a series of private financings in 2010, resulting in aggregate gross proceeds to the Company of approximately $21.6 million.  The Company intends to use the proceeds from these financings for general corporate purposes, including working capital, and to fund development activities for its lead product candidate, CNDO-109, including the initiation of a Phase 2 clinical trial in the US in patients with advanced acute myelogeous leukemia (AML).  Paramount BioCapital, Inc. acted as lead placement agent for the financings.

CNDO-109 is a biological product based on in-licensed technology that activates natural killer (NK) cells harvested from close relatives of cancer patients or from the patient  for the therapy of a wide-range of difficult to treat blood and solid tumor cancers.

Based on the results of a recently-completed Phase 1 open-label, uncontrolled clinical trial of CNDO-109 therapy in adult AML patients conducted at the Royal Free Hospital in London, the Company intends to file a Investigational New Drug application (IND) with the US Food and Drug Administration and to pursue a multicenter Phase 2 clinical trial for AML patients in the US, which the Company expects to commence in 2011.

Glenn L. Cooper, MD has joined the Company as Executive Chairman and Acting Chief Executive Officer, replacing R.J. Tesi, M.D., who has left the Company.  Dr. Cooper has 20 years of experience in the pharmaceutical and biotechnology industries, most recently as Chairman and Chief Executive Officer of Indevus Pharmaceuticals, which was acquired by Endo Pharmaceuticals in 2009 for an aggregate acquisition price that has the potential to reach $700 million.

Eric Rowinsky, MD, has joined the Company as Vice Chairman and will serve as a consultant with particular focus on
'/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
2. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
3. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
4. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
5. Neurocrine Biosciences, Inc. Prices Common Stock Offering
6. Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to HRBR
7. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
8. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
9. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
10. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 The law firm of Rheingold, Valet, Rheingold, ... to be the first suit in New York ... user of two common anti-diabetic drugs, Byetta and Janumet (also ... resident Robert Cataletto , was filed on ... E.D.N.Y. CV 13-3411. Mr. Cataletto received prescriptions from ...
(Date:6/17/2013)... June 17, 2013   Southern Research Institute ... has been selected by its Board of Directors to ... July 8, 2013.   (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ... Secrist, III, Ph.D., who served as president and CEO ... his retirement earlier this year after 34 years of ...
(Date:6/17/2013)... AVIV, Israel , June 17, 2013 ... the Board of Governors of the Israel-U.S. Binational Industrial ... million in funding for fourteen new projects between Israeli ... BIRD , the projects will access private sector ... approximately $33 million. The semi-annual meeting was held at ...
Breaking Medicine Technology:Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4
... 2011 Time is money, and time that is wasted looking ... A first-of-its-kind mobile and HTML5 app released by Providian Medical ... both time and money. With just a few quick and easy ... the optimum ultrasound machines based on their individual needs. The app ...
... SuccessEHS will sponsor the California Primary Care Association (CPCA) ... statewide leader and recognized voice representing the interests of ... CPCA represents more than 800 not-for-profit community clinics and ... SuccessEHS supports CPCA,s mission of eliminating ...
Cached Medicine Technology:Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2SuccessEHS Sponsors California Primary Care Association 2SuccessEHS Sponsors California Primary Care Association 3
(Date:6/17/2013)... social media push boosted the number of people who ... day, Johns Hopkins researchers found, suggesting social media might ... shortage in the United States. , The gains were ... created a way for users to share their organ ... make their status official on state department of motor ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
(Date:6/17/2013)... men with low-risk, localized prostate cancers can safely ... undergoing immediate treatment and have better quality of ... a study by researchers at Dana-Farber Cancer Institute ... June 18 issue of the Annals of ... models showed that "observation is a reasonable and, ...
(Date:6/17/2013)... Vegas Hotel Escapes, the top Las Vegas ... Berlin at the Lavo. Those traveling to Las Vegas to ... affordable rates we are offering. , VegasHotelEscapes is pleased ... hotels in Las Vegas on the strip , such as ... VegasHotelEscapes.com is pleased to offer the absolute lowest prices possible ...
(Date:6/17/2013)... Harvard Stem Cell Institute (HSCI) researchers have identified in ... to regulate embryonic stem cell self-renewal, beginning a creative ... , The gene, SALL4, gives stem cells their ability ... mature cells. Typically, cells only express SALL4 during embryonic ... cases of acute myeloid leukemia and 10 to 30 ...
Breaking Medicine News(10 mins):Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4Health News:Observation is safe, cost-saving in low-risk prostate cancer 2Health News:Observation is safe, cost-saving in low-risk prostate cancer 3Health News:A new target for cancer drug development 2
... the Sally Clark case could lead to a halving in the ... legacy emerging from tragedy, says a feature in this weeks BMJ. ... of her two infant sons. She was imprisoned but won her ... of the case, says Jonathan Gornall, have been devastating for her ...
... investigated and debated for its impact on health conditions ... effects on the body, coffee or its components ... levels on a short-term basis or cross-sectionally. These and ... risk of gout, the most prevalent inflammatory arthritis in ...
... over the past 40 years in England, owing to changes ... finds research published ahead of print in the British Journal ... geographical variation in rates suggest that the NHS is now ... training, say the authors. ,The research team analysed ...
... BMA says it is extremely concerned at the growing interest of ... the belief that these can be non lethal. ,The ... Science, concludes that it is impossible to deliver the right drug ... that is both effective and does not cause significant deaths. The ...
... an average of four to seven glasses of red wine ... with prostate cancer as those who do not drink ... Health Watch. In addition, red wine appears particularly protective against ... information about many factors that might influence the risk of ...
... A decade-long study by neurologists at the University of ... found a link between the increasingly popular weight-loss ... conditions. ,Katalin Juhasz Pocsine, M.D., associate ... author of the study. The study concludes that patients ...
Cached Medicine News:Health News:New Reforms Could Cut the Number of Unexplained Infant Deaths 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 3Health News:NHS Oversupplied With Cataract Surgery, Say Doctors 2Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2Health News:Link Between Gastric Bypass Surgery and Neurological Conditions 2
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... Innova 2100IQ: See the finest vessels from ... devices. Its all enabled by the Revolution ... deliver excellent image quality and dose efficiency. ... installed worldwide, more physicians rely on these ...
... as Antidiurectic Hormone (ADH), is synthesized in ... flow to the posterior pituitary for storage ... by changes in blood osmolality and also ... blood volume or arterial pressure. Non-osmotic stimuli ...
Medicine Products: